đź“Ł Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression. (2023)

First Author: González-Martínez I
Attributed to:  Preclinical Development of Peptide Oligonucleotides for Myotonic Dystrophy Type 1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtn.2023.09.001

PubMed Identifier: 37744174

Publication URI: http://europepmc.org/abstract/MED/37744174

Type: Journal Article/Review

Volume: 34

Parent Publication: Molecular therapy. Nucleic acids

ISSN: 2162-2531